← Back to all trials
Active Not Recruiting
NCT03130244
Procedure for Duodenum to Ileal Diversion to Treat Type 2 Diabetes
Conditions: Type 2 Diabetes, Obesity
Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: No
Phase: NA
Enrollment: 15
Sponsor: GI Windows, Inc.
Location: Aleman Hospital Buenos Aires
Summary
Study will monitor changes in HbA1c for subjects in Intervention arm vs control arm.
Eligibility Criteria
Inclusion Criteria:
* Body mass index (BMI) 30 to 50.
* Subject Type 2 Diabetes Criteria:
1. T2DM diagnosis ≥6 months but \< 10 years
2. On 1 or more oral diabetes medications (with one at the minimum recommended therapeutic dose)
3. Hemoglobin A1C (HbA1c) between and including 6.5 and 10.0% (58 mmol/mol to 86 mmol/mol) at time of enrollment and has had a stable HbA1c over a 3-month period (i.e., \
Source: ClinicalTrials.gov (NCT03130244). StuddyBuddy aggregates publicly available trial information.
